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Abstract
Dysregulation in immune responses during pregnancy increase the risk of a having a child with an 
autism spectrum disorder (ASD). Asthma is one of the most common chronic diseases among 
pregnant women, and symptoms often worsen during pregnancy. We recently developed a mouse 
model of maternal allergic asthma (MAA) that induces changes in sociability, repetitive and 
perseverative behaviors in the offspring. Since epigenetic changes help a static genome adapt to 
the maternal environment, activation of the immune system may epigenetically alter fetal 
microglia, the brain’s resident immune cells. We therefore tested the hypothesis that epigenomic 
alterations to microglia may be involved in behavioral abnormalities observed in MAA offspring. 
We used the genome-wide approaches of whole genome bisulfite sequencing to examine DNA 
methylation and RNA sequencing to examine gene expression in microglia from juvenile MAA 
offspring. Differentially methylated regions (DMRs) were enriched for immune signaling 
pathways and important microglial developmental transcription factor binding motifs. Differential 
expression analysis identified genes involved in controlling microglial sensitivity to the 
environment and shaping neuronal connections in the developing brain. Differentially expressed 
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associated genes significantly overlapped genes with altered expression in human ASD cortex, 
supporting a role for microglia in the pathogenesis of ASD.
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Maternal Immune Activation; Maternal Allergic Asthma; Autism Spectrum Disorders; DNA 
methylation; Microglia
Introduction
Epigenetic mechanisms fine tune gene expression during the development and maturation of 
the nervous and immune systems (Vogel Ciernia and LaSalle, 2016) resulting in long-lived 
phenotypic alterations without changing DNA sequence. Epigenetic mechanisms such as 
DNA methylation can be altered by environmental changes during a particular critical 
window in early life (Dolinoy et al., 2007; Jirtle and Skinner, 2007). The developing 
mammalian brain is particularly sensitive to epigenetic alterations, as mutations in 
epigenetic effectors can result in human neurodevelopmental disorders (Lasalle, 2013; Vogel 
Ciernia and LaSalle, 2016). Epigenetic changes are thought to adapt a static genome to a 
dynamic environment, providing an important interface between genetic and environmental 
risk factors in the complex etiology of autism spectrum disorders (ASD).
Epidemiological reports suggest a strong association between periods of maternal immune 
activation (MIA) during pregnancy and an increased risk of having a child with ASD 
(Atladottir et al., 2009, 2010, Zerbo et al., 2013, 2015). Early case reports and small 
comparative studies focused on infections during pregnancy associated with ASD risk 
(Chess, 1977; Sweeten et al., 2004; Libbey et al., 2005). Large population based studies in 
Denmark showed that mothers with severe infections during pregnancy that required 
hospitalization were at increased risk of having a child with ASD (Atladottir et al., 2010); a 
finding also confirmed in a Californian cohort (Zerbo et al., 2013). Moreover, taking 
antipyretic medication to reduce fever during pregnancy eliminated this increased risk for 
ASD (Zerbo et al., 2013), suggesting that treating the MIA attenuates risk. In addition to 
infections, associations of risk for ASD with autoimmune and immunological conditions 
such allergy, asthma, celiac disease, type-1 diabetes, autoimmune thyroid disease, psoriasis, 
rheumatoid arthritis, and rheumatic fever have been reported (Croen et al., 2005; Mouridsen 
et al., 2007; Atladottir et al., 2009; Mostafa and Kitchener, 2009; Keil et al., 2010), 
providing additional evidence for maternal immune dysfunction and increased risk of ASD.
Asthma is one of the most common chronic diseases among pregnant women. During 
pregnancy the median percent of women hospitalized for acute exacerbations of asthma is 
6% (Murphy et al., 2005, 2006, Ali and Ulrik, 2013a; b); however, in a study of 330 women 
with asthma, symptoms worsened in as many as 35% during pregnancy (Schatz et al., 1988). 
A large epidemiological study demonstrated that mothers with new onset allergies and 
asthma during the time of pregnancy were at increased risk for having a child with ASD 
(Croen et al., 2005). A separate study that looked at maternal allergies and asthma, 
irrespective of whether they were new onset or existing conditions, also found increased risk 
with certain allergies and ASD (Lyall et al., 2014). Recently we identified a profile of 
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elevated serum cytokines midgestation in women who gave birth to a child later diagnosed 
with ASD (Goines et al., 2011; Jones et al., 2017). This cytokine profile of elevated 
interleukins IL-4 and IL-5 was consistent with an allergic asthma clinical phenotype 
(Magnan et al., 2000; Cho et al., 2005; Tamasi et al., 2005; Kumar et al., 2006). 
Furthermore, a different midgestation maternal cytokine profile of elevated IL-6 and IL-2 
was associated with having a child with other developmental disorders, but not ASD (Goines 
et al., 2011). Amniotic fluid taken from children later diagnosed with ASD also had elevated 
levels of IL-4 whereas those with developmental delay had increased levels of IL-6 
(Abdallah et al., 2012). These reports implicate asthma/allergy and associated cytokine 
responses as a potential contributing factor to the development of ASD.
Previous work in animal models examining the impact of gestational MIA on ASD-like 
behaviors of the offspring have focused on viral and bacterial responses, using polyinosinic-
polycytidylic acid (polyI:C) or lipopolysaccharide (LPS) as experimental models 
(Whitehead et al., 2003; Nials and Uddin, 2008). However, allergies and asthma represent an 
alternative inflammatory response mediated by T-helper type 2 cells (TH2) that produce a 
different cytokine profile that may uniquely alter brain development relevant to ASD. We 
recently developed the first preclinical model of maternal allergic asthma (MAA) that 
produces the hallmark immunological responses in the MAA treated dams analogous to 
those observed in humans, including allergic airway inflammation and elevated levels of 
IL-4 and IL-5 (Schwartzer et al., 2015). MAA produced a phenotype in the offspring of 
impaired social approach and increased repetitive behaviors at both juvenile and adult ages 
(Schwartzer et al., 2015, 2017) that resemble behavioral features of ASD (Thomas et al., 
2009). MAA challenge in gestation also resulted in altered brain neurochemistry in offspring 
similar to those observed in ASD (Schwartzer et al., 2015).
In humans, fetal exposure to maternal asthma led to epigenetic alterations in DNA 
methylation patterns in peripheral blood samples of the offspring (Gunawardhana et al., 
2014). Notably, hypo-methylation in immune signaling gene MAP8KIP3 in fetal blood 
correlated with blood eosinophils, nitric oxide levels, and total serum IgE in the mother 
(Gunawardhana et al., 2014), suggesting that human MAA responses may be related to 
additional epigenetic changes in the offspring. These findings are consistent with previous 
work which found histone acetylation (Tang et al., 2013) and DNA methylation (Basil et al., 
2014; Richetto et al., 2016) changes in brain from juvenile and adult offspring in the polyI:C 
MIA mouse model. Together these results suggest that epigenetic changes within the 
immune cells of the brain may be responsible for the long-lived behavioral changes of 
offspring exposed to gestational MAA.
Within the brain microglia are brain-resident macrophages derived from erythro-myeloid 
precursors from the embryonic yolk sac that contribute to brain homeostasis and shaping 
synaptic and long-range neuronal connections (Tremblay et al., 2010; Paolicelli et al., 2011; 
Schafer et al., 2012; Hashimoto et al., 2013; Zhan et al., 2014). Microglia monitor and 
respond to their environment via specific cell surface receptors and secreted molecules, 
thereby acting as sentinel cells of tissue stress and injury (Murray and Wynn, 2011). The 
gestational timing of MAA may lead to alteration in microglial activity during key 
organizational phases of prenatal development producing long lasting changes in neural 
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circuitry. Microglia arise from the yolk sac myeloid progenitors, migrate to the brain and 
colonize the neural folds during embryogenesis with minimal replacement from peripheral 
monocytes (Squarzoni, 2015), suggesting that any perturbations to microglia in early 
development may also persist through adulthood. To test the hypothesis that gestational 
MAA is associated with long-lived ASD-relevant epigenetic changes in microglia, we 
performed genome-wide analyses of the DNA methylome and transcriptome of microglia 
isolated from juvenile offspring. The results of this study provide genome-wide evidence 
that gestational MAA alters DNA methylation of key immune regulatory elements and 
transcription of genes dysregulated in human ASD brain, supporting the validity of the 
MAA mouse model, microglia as a relevant cell type, and maternal asthma as an ASD risk 
factor.
Materials and Methods
Animals
All experiments used C57Bl/6J mice from Jackson (Jax strain 000664). All experiments 
were conducted in accordance with the National Institutes of Health Guidelines for the Care 
and Use of Laboratory Animals. All procedures were approved by the Institutional Animal 
Care and Use Committee of the University of California, Davis.
Maternal Allergic Asthma Paradigm
The MAA paradigm was conducted as previously described (Schwartzer et al., 2015, 2017). 
Briefly, on postnatal day (P) 42 and 49 sexually naive female C57Bl/6J mice were sensitized 
with a single intraperitoneal injection of 10 μg ovalbumin (OVA, Sigma, St. Louis, MO 
USA) in 1 mg (Al)OH3 (InvivoGen, San Diego, CA USA) dissolved in 200 μl phosphate 
buffered saline (PBS). One week following the second sensitization treatment, female mice 
were mated overnight and checked daily for the presence of a seminal plug, noted as 
gestational day 0.5 (G0.5). Pregnant mice were randomly assigned to either the allergic 
asthma or control group and exposed to either an aerosolized solution of 1% (wt/vl) OVA in 
PBS (MAA group) or vehicle control for three 45-minute induction on gestational days 9.5, 
12.5, and 17.5, to correspond with early, middle, and late gestation. Following the final 
induction, mice were returned to their home cages, single housed, and left undisturbed until 
the birth of their litters. Pups remained with their mother until weaning on P21, at which 
time the offspring were group housed with same-sex littermates. For all experiments female 
offspring were chosen for analysis due to previously identified increased microglial 
reactivity at P30 in females compared to males (Schwarz et al., 2012). Female MAA 
offspring also show a similar behavioral phenotype to male MAA offspring with deficits in 
social interactions, increased marble burying and decreased grooming (Schwartzer et al., 
2015, 2017).
Microglial Isolation P35
P35 female mice were deeply anaesthetized with CO2 and then quickly perfused 
intracardially with ice-cold PBS. Whole brains were removed and stored on ice in HBSS 
without Ca2+/Mg2+ until processed. Each brain was gently homogenized to a single cell 
solution using a dounce homogenizer, then added to 1.8 ml of isotonic Percoll to form a 30% 
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isotonic Percoll solution. Isotonic Percoll gradients were then constructed with layers of 
70% with 1× phenol red, 37% and 30%. The resulting gradients were centrifuged for 30 min 
at 500×g at room temperature. The top layer of myelin and non-microglial cells were 
discarded and the microglia at the interface between the 37% and 70% layers were collected. 
The resulting microglia were then washed in HBSS and counted. The collected cells were 
immediately flash frozen for RNA/DNA extraction. Given the low yield from individual 
animals, an additional animal was run in parallel and harvested microglia were used to 
assess purity by flow cytometry for CD45.2 and CD11b. Gating was first performed on live 
single cells (96%). Any highly granular myelin contamination was removed (92% 
remaining). From that >90% was microglia (CD45.2 and CD11b positive). The remaining 
≈6% (CD45.2 positive, but CD11b negative) represent a minimal contamination of other 
mononuclear cells (Figure S1).
RNA sequencing library preparation and sequencing
RNA and DNA were isolated from the same isolated microglia samples using ZR-Duet 
RNA/DNA kit (Zymo, D7001) with on-column DNase digestion (Qiagen, 79254) for RNA 
extraction. RNA and DNA were quantified using Qubit High Sensitivity assays. RNA 
quality was assessed by Bioanalyzer and only samples with RNA Integrity Number (RIN) 
scores greater than 7 were used for library preparation. 60–100 ng of input RNA per sample 
were used for RiboGone rRNA removal (Clonetech, 634847). 2 ng of rRNA depleted RNA 
per sample was then used for library construction using the SMARTer Stranded RNA-Seq 
kit (Clontech, 634836) and 14 cycles of PCR amplification. Library quality was assessed 
using a bioanalyzer and quantified by Qubit high sensitivity assay. All samples were 
barcoded, pooled, and run on a single sequencing lane of a HiSeq3000 to generate 50 bp 
single end reads. RNA-seq reads were analyzed for both quality and adapter contamination 
using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). All reads were 
trimmed using Trimmomatic (Bolger et al., 2014) using Illuminaclip single end adapter 
trimming, a removal of the first three bp from the 5′ as recommended for SMARTer 
libraries, and a 4 bp sliding window trim for quality scores less than 15. All remaining reads 
greater than 15 bp were then reanalyzed using FASTQC to verify quality. Potential library 
contamination was examined by aligning 100,000 reads from each sample to genomic 
sequences from E. coli, mouse (mm10, including rRNA and mtDNA), human (hg38), and 
PhiX using FastQ Screen (http://www.bioinformatics.babraham.ac.uk/projects/
fastq_screen/).
RNA sequencing PCA analysis
Principle Component Analysis (PCA) was conducted on read counts from published cell 
type specific RNA sequencing (Zhang et al., 2014; Mo et al., 2015) with normalization for 
library size. Raw Fastq files for each cell type were downloaded from GEO (GSE63137 and 
GSE52564) and processed as described except for paired end sequencing. PCA analysis was 
conducted on the top 500 most variably expressed genes across all cell types using custom R 
scripts. To further assess microglial purity subsampling of the aligned reads for both 
neuronal and microglial samples(Zhang et al., 2014) (GEO GSE52564) were performed to 
match the average 3×107 reads/sample (Table S2) obtained in this experiment. Specific 
proportions of randomly selected reads were then extracted from the neuron and microglial 
Ciernia et al. Page 5
Glia. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
samples, combined, counted and processed in EdgeR with normalization for total library 
size. Proportions for each combined mixed sample are listed in Figure S1.
RNA sequencing differential expression analysis
RNA-seq reads were aligned to the current mouse genome mm10 using the splicing-aware 
aligner Tophat2 (v2.0.14/bowtie2.2.5, stranded, Single End)(Kim et al., 2013) and reads 
aligning to each gene were counted using FeatureCounts (Liao et al., 2014) with exclusion 
of multimapping reads. The resulting table of counts per gene and sample was analyzed 
using the EdgeR pipeline (Robinson et al., 2010). Lowly expressed genes (less than 1 count 
per million reads in at least three biological replicates from either MAA or PBS groups) 
were removed from the analysis and the remaining reads were normalized for library size 
and RNA composition using the calcNormFactors function with trimmed mean of M-size 
method (Robinson and Oshlack, 2010). The normalized libraries were then fed into a one 
factor model (MAA vs. PBS) with a zero intercept. Both common and tagwise dispersions 
were estimated using estimateDisp and the resulting model was used for differential 
expression using exactTest and topTags with a filter for false discovery rate < 0.05. All 
differential expression analysis was performed on normalized counts per million (CPM) 
mapped reads. For graphical comparison of selected genes of interest and heatmap 
generation Reads per kilobase of transcript per million mapped reads (RPKM) was 
calculated using the built-in rpkm function that normalized for gene length. Gene Ontology 
and Pathway enrichment for differentially expressed genes were conducted using Enrichr 
(http://amp.pharm.mssm.edu/Enrichr/enrich) (Chen et al., 2013; Kuleshov et al., 2016) and 
then trimmed using REVIGO (http://revigo.irb.hr/) (Supek et al., 2011).
Whole Genome Bisulifte sequencing (WGBS) analysis
WGBS libraries were constructed using the Illumina EpiGnome/TruSeq DNA Methylation 
kit (Illumina, EGMK81312) with indexing barcodes (Illumina, EGIDX81312). 100 ng of 
DNA from each sample was bisulfite converted using the EZ DNA Methylation-Lightning 
kit (Zymo, D5030). Each library was given a unique barcode identifier and 14 cycles of PCR 
amplification. Libraries were quantified by Qubit and quality was assessed by Bioanalyzer. 
Sequencing of barcoded and pooled libraries was performed across two lanes of Illumina 
HiSeq4000 to obtain 100 bp single end reads.
After adapter trimming and quality assessment, all WGBS reads were mapped to the mouse 
genome (mm10) using the Bisulfite Seeker2 program (v2.0.8 with bowtie1.1.1) (Guo et al., 
2013) and subsequent analysis was done with custom Perl and R scripts (Dunaway et al., 
2016b). Differentially methylated regions (DMR) between experimental conditions was 
examined using the R packages DSS and bsseq (Feng et al., 2014). DMRs were identified as 
sets of CpGs with a t-statistic greater than the critical value for alpha 0.05 and with a gap 
between CpGs of less than 300 bases. DMRs were then filtered for those with more than 3 
CpGs, a mean methylation difference of greater than or equal to 10% between conditions, 
and an area stat of +/− 20. Further permutation testing was used to identify DMRs with a 
family wise error rate <0.05 based on 1,000 permutations of random shuffling of sample 
group assignment. The average difference in methylation was 29.94% for hyper-methylated 
and 31.57% for hypo-methylated DMRs. The average size of the hyper-methylated DMRs 
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were 492 bases with an average of 10 CpGs and hypo-methylated DMRs were on average 
composed of 450 bases and 10.9 CpGs.
DMRs were assessed for Ontology and pathway enrichment using Genomic Regions 
Enrichment of Annotations Tool (GREAT) with default settings for regulatory regions (5 kb 
+/− 1 kb of TSS and basal regulatory domain extension from nearest gene of 1Mb) (McLean 
et al., 2010) with filters for both significant binomial and hypergeometric tests (FDR < 0.05 
The resulting GO term lists were trimmed to remove redundancy using REVIGO. Motif 
enrichment within DMRs was assessed using HOMER (Heinz et al., 2010) (FDR < 0.05) 
and lists were filtered for motifs commonly identified in both hyper- and hypo-methylated 
DMRs, hypo-methylated DMRs only, or hyper-methylated DMRs only. Genes with 
transcription start sites within +/− 5kb of each DMR were identified using HOMER (Heinz 
et al., 2010).
In addition to global assessment of CpG and CpH methylation levels, CpG methylation over 
gene bodies, CpG islands, CpG shores (±2 kb from a CpG island), and tissue specific 
enhancer regions were also examined and tested for differential methylation using 
independent, two-tailed t-test with FDR correction and a minimum of 5 reads per region 
across all samples.
WGBS PCA analysis
PCA was conducted on percent mCG/CG from publish cell type specific WGBS (Lister et 
al., 2013; Mo et al., 2015). Raw Fastq files for each cell type were downloaded from GEO 
(GSE63137 and GSE47966) and processed as described for WGBS. Percent CG/CG 
methylation was extracted for 20 kb windows, gene bodies, and CpG islands for each 
sample. CpG Islands were masked from the analysis of the other two regions. PCA analysis 
was conducted on the top 500 most variable regions of each type for all cell types using 
custom R scripts.
Fluidigm Biomark HD Delta Gene Expression Assay
Gene expression for selected targets identified from RNAseq analysis were examined in an 
independent set of microglial samples isolated from PND35 female littermates of animals 
used for sequencing (Supplemental Table S3). Gene expression analysis was performed 
using the Fluidigm Biomark HD Delta gene assay on a 48.48 Integrated Fluidic Circuit. 
Delta gene assay design was performed by Fluidigm and primer sequences are listed in 
Supplemental Table S3. 20ng of total RNA was used as input for cDNA synthesis (Fluidigm, 
100–6472 B1) followed by pre-amplification (13ng per sample) (Fluidigm, 100–5875 C1) 
using a mix of all forward and reverse primers. Samples were then diluted five-fold and 
analyzed on a 48.48 IFC and Biomark HD machine (1.4ng/sample) in duplicate (Fluidigm, 
100–9791 B1). Cycle threshold values were averaged across replicates and then normalized 
to hprt expression (no difference in mean Ct values for hprt between conditions, t= 1.27, p = 
0.239) using the delta Ct method (Ct gene – Ct hprt). These values were then used for group 
comparisons with a two-tailed t-test without an assumption of equal variance. For display 
purposes, the delta delta Ct values were then calculated relative to the average Ct value of 
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the PBS treated control for each gene, and relative expression levels were then calculated for 
each group by 2^-delta delta Ct (Figure S4D).
Overlap of Gene lists
Gene list overlap was performed using the GeneOverlap (Shen, 2013) package in R with a 
Fisher’s exact test and a False Discovery Rate correction to p=0.05. Gene lists and 
references are listed in Table S7 (Voineagu et al., 2011a; Oskvig et al., 2012; Garbett et al., 
2012; Sugathan et al., 2014; Gilissen et al., 2014; Gunawardhana et al., 2014; Gupta et al., 
2014; Iossifov et al., 2014b; Cotney et al., 2015; Cronk et al., 2015; Sanders et al., 2015; 
Holtman et al., 2015; Matcovitch-Natan et al., 2016; Richetto et al., 2016; Rube et al., 2016; 
Dunaway et al., 2016b; Zhao et al., 2017; Lombardo et al., 2017). For comparisons to 
differentially expressed genes the background gene list was all genes identified as expressed 
in the RNAseq experiment (see above description) (14,301 genes). For comparisons to DMR 
associated genes, background genes were defined from a call to the DMR finder for mm10 
with no filters or cutoffs. This produces a list of all potential locations in the mm10 genome 
that could be called as a significant DMR. Genes associated with (+/− 5 kb) this background 
DMR set were used as the background list (22,412 genes). For comparisons between 
differentially expressed and DMR associated genes, a common background gene set was 
used that included the intersection of both the differentially expressed and DMR associated 
background gene list (13,694 genes that could have both been differentially expressed and 
within 5 kb of a DMR). All gene lists used in each comparison were filtered to include only 
genes present on the respective background list for that comparison. Drug target analysis 
was performed using The Drug Gene Interaction Database (dgidb.genome.wustl.edu)
(Dunaway et al., 2016b).
Results
Figure 1A shows the experimental design prior to microglial isolation. To induce a MAA 
response, female mice were pre-sensitized with OVA exposure at 6 and 7 weeks of age prior 
to breeding. Timed pregnant dams were then given three exposures to ovalbumin (OVA) 
during gestation (gestation day 9.5, 12.5, and 17.5) or three exposures to endotoxin free PBS 
to mimic immune challenge or control, respectively (Schwartzer et al., 2015).
While ASD has a pronounced sex-bias for males, both male and female MAA offspring 
show similar behavioral phenotypes deficits in social interactions, increased marble burying, 
and decreased grooming (Schwartzer et al., 2015, 2017). In rodents, adolescent females 
show increased microglial reactivity compared to males (Schwarz et al., 2012). 
Consequently, this study focused on characterizing juvenile microglia from female MAA 
offspring. In order to study the effects of in utero MAA on persistent microglial epigenomic 
signatures that coincide with the observance of ASD-like behaviors (Schwartzer et al., 2015, 
2017), microglia were isolated from juvenile mice from multiple litters (n= 4 mice from a 
total of 4 litters per condition) on P35. There were no significant differences in the number 
of microglia isolated or the RNA/DNA yields between the two treatment groups (Table S1).
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Microglial Methylome and Transcriptome Reveal Cell Type Specific Signatures
RNA sequencing was performed to examine differences in gene expression associated with 
MAA in juvenile microglia (n=4/group). There were on average 28.6 million uniquely 
mapped reads per sample and no differences in read depth or mapping between conditions 
(Table S2). All libraries passed FastQC assessment and none indicated significant sources of 
contamination during library preparation (Figure S1A & B).
We first sought to ensure that the gene expression patterns in both experimental conditions 
fit with expected microglial markers and gene expression patterns. To examine cell type 
specific gene expression patterns we compared the MAA and PBS microglia collected in 
this experiment to previously published RNA sequencing data on carefully sorted cell 
populations from mouse cerebral cortex (neurons, astrocytes, oligodendrocyte precursor 
cells, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, endothelial 
cells, and pericytes) (Zhang et al., 2014) and several specific types of neurons (excitatory, 
PV interneurons and VIP interneurons) (Mo et al., 2015). Both the PBS and MAA microglia 
transcriptomes cluster more closely with those of adult cortical microglia and are separated 
from those of other cortical cell types (Figure 2A). Further analysis of expression (reads per 
kilobase of transcript per million mapped reads, RPKM) values for cell type marker genes 
(Hickman et al., 2013; Zhang et al., 2014) revealed high expression of microglial markers 
and low expression of cell type specific markers from other cortical cell types (Figure 2B). 
In addition, subsampling microglial and neuronal reads from previously published RNAseq 
(Zhang et al., 2014) indicated that the percentage of neuronal RNA contamination in our 
microglial samples was minimal and between 0.2 to 4% (Figure S1C). Analysis by flow 
cytometry on samples prepared in parallel indicate a similar purity greater than 90% (Figure 
S1D).
To examine DNA methylation changes in P35 microglia between MAA and PBS treated 
samples using an unbiased genome-wide approach, we performed WGBS. There were no 
significant differences in sequencing coverage, bisulfite conversion, or in the global 
percentage of CG, CHG, or CHH methylation between treatments (Table S2). On average 
microglia showed similar levels of mCG and mCH as previously described in neurons 
(Lister et al., 2009). To examine cell type specific methylation patterns we compared 20 kb 
windows across the genome from the MAA and PBS microglia collected in this experiment 
to previously published WGBS data on several specific types of neurons (excitatory, PV 
interneurons and VIP interneurons) (Mo et al., 2015), astrocytes, and brain (P28) (Lister et 
al., 2013). Both the PBS and MAA P35 microglia samples cluster more closely with each 
other than with other cortical cell types, indicating microglia show a distinct methylation 
pattern from other brain cell types (Figure 2C). Similar patterns were observed over gene 
bodies and to a lesser extent over CpG islands (Figures S2A and B). There were no 
significant differences between MAA and PBS treatment groups in average percent CG 
methylation for a number of global genomic features, including gene bodies, 5 kb upstream 
promoter regions (with or without CpG islands), nor CpG islands (Figure S2C).
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Differentially Methylated Regions in MAA Offspring Microglia
To assess the long-term impact of MAA on epigenetic regulation in offspring microglia we 
identified locus-specific differentially methylated regions (DMRs) between MAA and PBS 
(Dunaway et al., 2016a; b). 1,184 DMRs were identified, with nearly equivalent numbers of 
hyper-methylated (626 MAA>PBS) and hypo-methylated (558 PBS>MAA) regions (Figure 
3A, Table S3). Three DMRs also passed family wise error rate (FWER) correction (Figure 
S2D). In general, MAA associated DMRs were largely localized within introns (40%) and 
intergenic sites (26%) (Figure 3B) indicating potential regulatory function.
Functional annotation was assigned to each DMR using GREAT, which included biological 
processes such as regulation of cell number, embryo development, and response to cytokine 
stimulus. Pathway analysis (Panther and MsigDB) showed enrichment for a number of 
immune pathways including inflammation mediated by cytokine and chemokine signaling 
such as IL-6, IL-4 and IL-8 signaling, as well as Jak-STAT, NF-κB, TNF and mTOR 
signaling (Figure 3C and Table S3). When specific enrichment was examined for MSigDB 
immune signatures, DMRs were found to be enriched for gene sets associated with LPS 
treatment and other types of immune cell activators (Table S3). Furthermore, genes with 
transcription start sites +/−5kb of DMRs (424 DMRs, total with 209 hyper-methylated 
DMRs and 215 hypo-methylated DMRs) (Table S5) were significantly enriched for genes 
responsive to LPS, and other immune stimuli in microglia (Figure 3D) (Hickman et al., 
2013; Holtman et al., 2015; Hanamsagar et al., 2017). Together these findings indicate that 
regions sensitive to MAA methylation differences may contain critical regulatory regions 
responsive to immune stimuli in microglia.
To evaluate potential transcription factor binding sites enriched within MAA-DMRs, we 
examined motif enrichment analysis using HOMER (Table S4). Motifs commonly enriched 
in hypo- and hyper-methylated DMRs include transcription factors related to a number of 
different functions including the SOX, SMAD, and TGFβ-induced families of transcription 
factors. Hyper-methylated DMRs were enriched for several interesting transcription factor 
motifs that are critical for early microglial development and immune activation including 
RUNX1, PU.1, IRF8, NF-kB, and MAFB. Hypo-methylated DMRs were enriched for 
several zinc finger and LIM homeobox proteins, together suggesting that regulation of 
inflammatory signaling and microglial developmental may be altered by DNA methylation 
differences in MAA microglia.
Differentially Expressed Genes in MAA Offspring Microglia
In order to understand how epigenomic differences in MAA offspring microglia were related 
to regulation of gene expression we examined differential gene expression patterns from the 
same microglial isolations that were profiled for DNA methylation. Differential expression 
between MAA and PBS samples was conducted using the standard EdgeR pipeline and 
revealed 162 differentially expressed genes at an FDR < 0.05 (Figure 4A & B and Table S5). 
Of these genes the vast majority showed greater expression in MAA samples compared to 
PBS (157 MAA>PBS). Gene Ontology enrichment analysis revealed significant enrichment 
of several categories of GO terms including gated and ion channel activity, synapse part, and 
regulation of cell projection organization (Figure S3A and Table S6). Pathway enrichment 
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using KEGG, Panther and Reactome revealed significant enrichment for pathways involved 
in a number of processes critical for neurodevelopment including several neurotransmitter 
systems, axon guidance, and synapse function (Table S6). While many of these gene targets 
are typically examined in neurons, microglia express GABAB, serotonin and dopamine, 
NMDA, AMAP, and kainic acid and metabotropic glutamate receptors that can be utilized to 
sample the local environment and consequently regulate activation, chemotaxis, secretion, 
proliferation and phagocytosis (Craner et al., 2005; Li et al., 2008; Black and Waxman, 
2012; Stebbing et al., 2015). Gene expression changes were further validated on an 
independent group of microglial samples using a Fluidigm Delta Gene Expression Assay on 
a selected subset of transcripts (Table S3B). With this independent method and cohort all 
transcripts validated the direction of expression change seen in the sequencing cohort (Table 
S5) with Hspalb levels reaching significance (p < 0.05) and Ina levels approaching 
significant (p < 0.07) (Figure S3B).
To investigate the relationship between MAA-induced methylation and expression changes, 
DMR associated genes were compared with differentially expressed genes. There was not a 
significant overlap between all differentially expressed genes and all genes associated with 
DMRs (Fisher’s exact test, Odds Ratio = 1.96, p = 0.116) with only 7 genes shared between 
the two lists (Figure 4C). There was also not a significant overlap with the 70 genes 
identified as associated with single site CpG differential methylation from blood from 
human infants from asthmatic mothers (Fisher’s exact test, all p > 0.05) (Gunawardhana et 
al., 2014). For the seven genes that did overlap between MAA differentially expressed and 
DMR associated genes, Pcdha9, Pax6 and Ina are all critical genes for normal 
neurodevelopment and are SFARI ASD risk genes (SFARI.org), suggesting that alterations 
in MAA microglial gene expression and methylation may impact similar pathways disrupted 
by ASD genetic mutations.
MAA Microglial Impacted Genes are Enriched for Genes Dysregulated in ASD
In order to more fully evaluate the impact of MAA on ASD-related risk genes we 
overlapped the differentially expressed and differentially methylated gene lists with 
previously published risk gene lists for ASD, schizophrenia, and intellectual disability (ID) 
(Sanders et al., 2012, 2015; Gilissen et al., 2014; Iossifov et al., 2014a) (Figure 5A and 
Table S7). Genes that were differentially expressed and genes that were associated with 
DMRs in MAA microglia significantly overlapped a hand curated list of SFARI ASD risk 
genes and genes with Likely Gene Disrupting (LGD) mutations in exome-sequencing from 
ASD probands (Iossifov et al., 2014). However, the majority of known genetic risk factors 
were not found within the MAA microglial gene lists, suggesting that MAA is largely 
targeting gene pathways independently impacted by genetic mutations linked to ASD and 
ID. This is not surprising given that the majority of genetic risk factors for ASD and ID are 
not immune-related (Needleman and Mcallister, 2012; Sanders et al., 2015). However, 
differences in gene expression profiling from human ASD brain have revealed changes in 
expression of immune signaling pathways and microglial genes (Voineagu et al., 2011; 
Gupta et al., 2014; Parikshak et al., 2016). To test the hypothesis that MAA microglia may 
show similar alterations in gene expression as human ASD brain samples, we overlapped the 
MAA microglial dysregulated genes with genes that showed altered expression or 
Ciernia et al. Page 11
Glia. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
differential epigenomic marks (DNA methylation or histone acetylation) in human ASD 
brain samples (Voineagu et al., 2011; Gupta et al., 2014; Dunaway et al., 2016b; Parikshak et 
al., 2016; Sun et al., 2016) (Figure 5B). Differentially expressed genes in MAA microglia 
significantly overlapped genes with lower expression in both idiopathic and genetic 
(15q11-13 duplication) forms of ASD as well as genes with increased acetylation. 
Furthermore, both MAA differentially expressed and DMR associated genes showed 
enrichment in a number of modules identified from network analysis of differential ASD 
gene expression from human ASD cortex (Gupta et al., 2014; Parikshak et al., 2016) (Figure 
5C and Table S7), suggesting some common pathways are disrupted in human ASD brain 
and MAA microglia.
The enrichment of dysregulated genes in MAA microglia with transcriptionally and 
epigenetically dysregulated genes in ASD brain suggests that MAA may alter similar 
pathways as those impacted by ASD. Consequently, we examined the overlap between 
MAA regulated genes and gene targets of three of the most commonly mutated regulatory 
factors implicated in ASD and ID: Fragile X Mental Retardation Protein (FMRP), 
Chromatin-Helicase DNA Binding Protein 8 (CHD8), and Methyl CpG Binding Protein 2 
(MeCP2) (Figure 4D). FMRP targets from mouse brain (Darnell et al., 2011) overlapped 
with both MAA differentially expressed and DMR associated genes (Figure 5D and Table 
S7) suggesting that key gene targets downstream of FMRP may also be impacted by MAA. 
Similar overlap between FMRP targets and genes acutely regulated 4 hours following LPS 
induced MIA has also been previously observed (Lombardo et al., 2017), suggesting that 
FMRP target genes may be specifically vulnerable to maternal inflammation. There was no 
significant overlap between either MAA gene list and identified CHD8 target genes from 
multiple datasets (Sugathan et al., 2014; Cotney et al., 2015). MAA DMR associated genes 
were enriched in MeCP2 target genes identified from high resolution ChIP-sequencing from 
olfactory epithelium neurons (Rube et al., 2016), suggesting MeCP2 may be associated with 
sites of MAA differential methylation. MeCP2 has previously been implicated in microglial 
function in Rett syndrome (Derecki et al., 2012; Cronk et al., 2015; Schafer and Stevens, 
2015), and microglia from Rett mouse models show altered gene expression patterns related 
to glucocorticoid signaling and stress response (Cronk et al., 2015; Zhao et al., 2017). Genes 
differentially expressed in Rett syndrome mouse model microglia overlapped both MAA 
differentially expressed and DMR associated genes (Figure 5E and Table S7), further 
supporting the role for MeCP2 as a reader of DNA methylation in microglia and indicating 
that MeCP2 function may be negatively impacted in MAA microglia.
MAA Offspring Microglia Compared to Other MIA Models
Maternal immune activation has been utilized as a model of ASD as well as schizophrenia 
and general neurodevelopmental impairment (Hagberg et al., 2012; Mattei et al., 2017). The 
MAA model was originally designed to examine allergic asthma as a risk factor for ASD, 
but the model may be applicable to other neurodevelopmental disorders that share maternal 
immune activation as a risk factor. To compare our MAA model to other MIA models we 
overlapped the MAA gene lists with published datasets from maternal exposures to LPS, 
PolyI:C, influenza, or direct cytokine injection. DNA methylation in MAA microglia and 
whole prefrontal cortex from PolyI:C induced MIA (Richetto et al., 2016) showed similar 
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patterns of differential methylation (Figure S4A) suggesting the long-lasting DNA 
methylation signatures in the brain may be target similar pathways across MIA/MAA 
models. In comparison, our MAA differentially expressed and DMR associated microglial 
gene lists largely did not overlap with whole brain gene expression patterns induced four 
hours following different types of MIA (LPS, recombinant IL6, PolyI:C) (Figure S4B and 
Table S7). The one exception to this was a significant overlap with genes acutely 
downregulated in response to LPS MIA. There were mixed findings for gene overlap with 
microglia isolated from PolyI:C MIA models. MAA microglial gene lists did not overlap 
dysregulated genes identified in a PolyI:C MIA model from isolated microglia from whole 
brain on P0 or P28 (Matcovitch-Natan et al., 2016) (Figure S4B). However, MAA 
differentially expressed genes significantly overlapped with genes that were up-regulated in 
a PolyI:C MIA model from hippocampal microglia from adult animals (Mattei et al., 2017) 
(Figure S4C) suggesting that MAA may impact hippocampal microglia. Interestingly, both 
MAA differentially expressed and DMR associated gene lists overlapped genes that were 
responsive to minocycline treatment in adult MIA animals (Mattei et al., 2017) (Figure 
S4C), indicating that minocycline may serve as a potential therapeutic for reversing some of 
the MAA offspring phenotypes.
Discussion
In this study we identified epigenetic changes in microglia from juvenile offspring of MAA 
dams that advance the understanding of maternal immune activation and ASD risk in several 
important ways. We found differentially methylation regions enriched for transcription 
factor binding sites related to immune signaling, microglial inflammation, and regulation of 
microglial development. This immune related methylome signature in MAA offspring 
microglia implicates altered epigenomic regulation of microglial inflammatory responses as 
a result of MAA. Importantly for ASD relevance, transcriptome profiling of MAA microglia 
identified key developmental genes related to synaptic function that are also misregulated in 
human ASD brain.
The gestational timing of MAA may preferentially affect changes in microglial function in 
offspring, a perturbation that may be marked by changes in DNA methylation that persist as 
microglia develop. Microglia migration to the brain and colonization of the neural folds 
during embryogenesis with minimal turnover (Squarzoni, 2015), suggesting that 
perturbations to microglia in early development may be maintained throughout the lifetime 
of the animal. Previous work with PolyI:C MIA demonstrated long-lasting alterations in 
histone modifications (Tang et al., 2013) and DNA methylation (Basil et al., 2014; Richetto 
et al., 2014, 2016) in adult brain that stem from in utero exposures at mid gestation. While it 
is unclear if the methylation changes in juvenile MAA microglia are direct or secondary 
impacts from MAA, the enrichment for numerous immune related pathways including IL-6, 
IL-4, and IL-8 signaling, NF-kB activation and JAK/STAT signaling, suggests that DMRs 
may either serve as a signature of prior immune activation during gestation or as epigenetic 
mechanisms for priming future immune function. The enrichment of DMRs for IL-4 
signaling is consistent with the cytokine profile of elevated IL-4 and IL-5 observed in 
asthma (Magnan et al., 2000; Cho et al., 2005; Tamasi et al., 2005; Kumar et al., 2006), the 
mid-gestation serum cytokines profiles observed in women who gave birth to a child later 
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diagnosed with ASD (Goines et al., 2011; Jones et al., 2017), and in amniotic fluid taken 
from children later diagnosed with ASD (Abdallah et al., 2012). Similarly, the enrichment of 
DMRs for a number of transcription factor motifs critical for early development of microglia 
(RUNX1, PU.1, and IRF8) indicate that MAA may shift the developmental regulation of 
microglial function. For example, RUNX1 is expressed in microglial yolk sac progenitors 
and plays a critical role in regulating microglial proliferation in early brain development 
(Ginhoux et al., 2010) by ensuring that developing microglia transition from an amoeboid to 
mature, ramified state during differentiation (Zusso et al., 2012). Similarly, PU.1 is a pioneer 
transcription factor with DNA methylation sensitive binding (Stephens and Poon, 2016) 
critical for microglia progenitor development (Kierdorf et al., 2013; Goldmann et al., 2016), 
regulates microglia specific enhancers (Gosselin et al., 2014) and gene expression (Satoh et 
al., 2014). PU.1 and shows increased expression in human ASD brain(Gupta et al., 2014), 
and manipulations of PU.1 alter the expression of key microglial genes and phagocytosis 
function (Huang et al., 2017), indicating that changes in PU.1 binding could dramatically 
alter microglial function in ASD. Future studies will be needed to examine the impact of 
MAA on microglia from different stages of development and in altering the transcriptional 
response to secondary immune activation (i.e. LPS).
In human ASD brain samples, whole genome analysis has identified alterations in DNA 
methylation (Nardone et al., 2014; Dunaway et al., 2016b) and gene expression (Voineagu et 
al., 2011; Gupta et al., 2014; Werling et al., 2016) of a number of immune related genes 
including components of the complement cascade C1Q, C3, ITGB2 and the cytokine TNFα. 
Several studies have identified alterations in microglia morphology and density in post-
mortem brain samples from ASD patients (Vargas et al., 2005; Morgan et al., 2010, 2012, 
2014; Tetreault et al., 2012). In at least a subset of ASD cases, microglia adopt an immune 
activated morphology characterized by retraction and thickening of processes and 
enlargement of the soma in multiple brain regions including the dorsolateral prefrontal 
cortex (Morgan et al., 2010), amygdala (Morgan et al., 2014), and cerebellum (Vargas et al., 
2005). Using positron emission tomography and a radiotracer for microglia, Suzuki and 
colleagues found evidence for increased microglia activation in multiple brain regions in 
young adults with ASD (Suzuki et al., 2013). Given that immune system related genes are 
not highly prevalent among the genetic candidates for ASD risk, the alterations in expression 
and methylation of immune genes in ASD may occur in reaction to abnormal 
neurodevelopment and/or in response to environmental factors such as maternal immune 
activation.
The significant overlap of MAA differentially expressed genes with genes differentially 
expressed or differentially acetylated in ASD brain provides support for the role of maternal 
immune dysregulation in the etiology of ASD. MAA may also impact some of the same 
downstream transcriptional pathways that are regulated by MeCP2 and FMRP. While FRMP 
was not a direct target of MAA in our data, Cytoplasmic FMRP Interaction Protein 2 
(Cyfip2) had an intronic hyper-methylated DMR in the MAA microglia. CYIFP2 expression 
is altered in Fragile X-syndrome (Hoeffer et al., 2012) and defective CYFIP/FMRP 
interactions have been implicated in ASD and ID (Abekhoukh and Bardoni, 2014) and may 
mediate some of the overlapping genes targeted by FMRP and regulated by MAA. MeCP2 
expression was also not altered by MAA, but genes targeted by MeCP2 binding and genes 
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sensitive to loss of MeCP2 in microglia significantly overlapped MAA genes, indicating 
MeCP2 may play a role in regulating gene expression differences in MAA microglia.
The vast majority of differentially expressed genes in MAA microglia showed a significant 
increase in expression relative to PBS controls. While not expected, this increase in 
expression is consistent with other MIA experiments in whole brain examining acute 
responses to MIA treatments (Garbett et al., 2012), suggesting an increased sensitivity to 
environmental signals. For example, we found increased expression of voltage-gated 
calcium channel subunit Cacna1b, voltage-gated potassium channel subunits (Kcnab1 and 
Kcnd2), and voltage-gated sodium channel subunits (Scn1a, Scn2a, and Scn2b). Canca1b, 
Kcnd2 and Scn1a are also ASD candidate genes and increased expression of a number of 
ligand-gated ion channels upon MAA could lead to altered function (Eder, 1998; Craner et 
al., 2005; Schilling and Eder, 2007, 2015; Li et al., 2008; Black et al., 2009; Wu et al., 2009; 
Black and Waxman, 2012; Stebbing et al., 2015). Increased surface receptor expression in 
MAA microglia would be consistent with motif enrichment of DMRs for transcription 
factors related to adult homeostatic function in microglia (FOS, MEF2A, MAFB)
(Matcovitch-Natan et al., 2016). For example, MAFB expression is induced during 
microglial maturation, its motif is enriched in macrophage-specific enhancers, and deletion 
of Mafb specifically in microglia increases gene expression for immune and viral response 
genes (Matcovitch-Natan et al., 2016). Together these findings suggest that MAA results in 
long-lasting changes in the ability of microglia to sense and respond to changes in the local 
brain environment. Altered sensitivity of MAA microglia could potentially dramatically alter 
the key role of microglia in sculpting neuronal connections and neuronal cell number in the 
developing brain (Tremblay et al., 2010; Paolicelli et al., 2011; Hagberg et al., 2012; Schafer 
et al., 2012; Zhan et al., 2014), as further suggested by enrichment of MAA differentially 
expressed genes for pathways involved in regulation of cell projection organization, neuronal 
differentiation, and neuronal apoptotic processes (Table S6). Experimentally removing or 
manipulating microglia in fetal life or during transient postnatal stages has been 
demonstrated to have profound effects on the number and strength of neuronal synapses, 
neuronal circuit development, and behavior (Paolicelli et al., 2011; Cunningham et al., 2013; 
Zhan et al., 2014; Kim et al., 2016). Previous work showed that early life perinatal 
inflammation (LPS GD15 and 16) augmented fetal microglia activity and decreased 
neuronal precursors in the developing rat cerebral cortex (Cunningham et al., 2013), leading 
to impaired corpus callosum fasciculation (Pont-Lezica et al., 2014), dopaminergic axon 
outgrowth (Squarzoni et al., 2014), and alterations in glutamatergic synapses in the adult 
offspring (Roumier et al., 2008). Our results show that MAA microglia have significant 
transcriptional and epigenetic alterations to genes important in axon guidance and receptor 
function that are consistent with altered sensitivity to the environment and neuronal circuit 
development.
One potential limitation of our study was a low level of neuronal contamination (0.2-2% in 
control versus 0.5-4% in MAA, Fig. S1C) in our microglial isolations due to the inherent 
microglial-neuronal interactions including phagocytosis that occur in brain. While our 
microglia isolations were above the purity of another published microglial transcriptome 
study (Zhao et al., 2017), we cannot be certain that the higher expression of some of the 
typically neuronal genes were cell intrinsic to microglia rather than a result of increased 
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neuronal phagocytosis in the MAA brain (Solga et al., 2015), although either explanation is 
of interest for understanding the pathogenesis. While the function of many of these 
neurotransmitter receptors on microglia is largely unknown (Schafer et al., 2013), their 
overall increase in expression following MAA suggests that microglia have altered 
sensitivity in the juvenile MAA brain. This is consistent with recent work from a PolyI:C 
MIA model that showed altered gene expression of cell surface receptors and phagocytosis 
activity of adult hippocampal microglia (Mattei et al., 2017). Genes misregulated in this 
model overlapped the MAA differentially expressed genes indicating shared molecular 
pathways and functions may be disrupted. In addition, MAA impacted genes also 
overlapped genes responsive to adult minocycline treatment in this MIA model, suggesting 
minocycline may be able to similarly reverse the behavioral, gene expression and microglial 
functional deficits in the MAA offspring. Alternatively, many of the receptors showing 
increased expression in MAA offspring microglia are identified drug targets for a variety of 
pharmaceuticals (Table S6) that may provide novel options for therapeutics, as is being 
explored in other neurologic disorders (Eder, 2010).
This work provides a novel link between maternal allergic asthma and changes in the 
microglial epigenome, indicating that microglia may serve as a potential therapeutic target 
for normalizing fetal brain connectivity deficits observed in ASD. Removal of microglia 
from the adult mouse brain by pharmacological treatment did not negatively impact adult 
behavior (Elmore et al., 2014, 2015) and improved behavioral deficits in an Alzheimer’s 
disease model (Rice et al., 2015), suggesting microglial contributions to neuro-immune 
dysfunction can be reversed in the adult. Given the emerging importance of microglia to 
multiple neuropsychiatric disorders, uncovering the microglial epigenetic landscape is the 
first step towards understanding how in utero exposures may influence microglia function 
and dysfunction in later life. Together, our findings present the first whole genome 
evaluation of microglial DNA methylation and support a role for maternal immune 
activation in altering microglial function as part of the pathogenesis of ASD.
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Main Points
• Maternal allergic asthma induces changes in DNA methylation and 
transcription in juvenile offspring microglia
• Differentially methylated regions are enriched for functions and transcription 
factor binding motifs involved in inflammation and microglial development
• Differentially expressed genes and differentially methylated regions are 
enriched for genes dysregulated in Autism Spectrum Disorders
Ciernia et al. Page 26
Glia. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Maternal Allergic Asthma Model
A. Maternal allergic allergy/asthma (MAA) was induced by pre-sensitizing dams to 
ovalbumin (OVA) prior to mating. During subsequent pregnancy half of the dams were 
challenged with OVA (gestation day (GD) 9,12, and 17) and the other half received PBS. 
Microglia were then harvested from the resulting female pups on postnatal day 35 (P35). 
Male pups were used for behavioral assessment as part of a recently published study 
(Schwartzer et al., 2017).
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Figure 2. Microglial Transcriptome and Methylome Reveal Cell Type Specific Signatures
A. Principle component analysis of the gene counts from the top 500 most variably 
expressed genes across multiple brain cell types (neurons, astrocytes, oligodendrocyte 
precursor cells, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, 
endothelial cells, and pericytes (Zhang et al., 2014) and several specific types of neurons 
(excitatory, PV interneurons and VIP interneurons (Mo et al., 2015)). B. RPKM values for 
selected cell type marker genes (Hickman et al., 2013; Zhang et al., 2014) for MAA and 
PBS samples (n=4/group). Oligodendrocyte precursor cells (OPC), newly formed 
oligodendrocyte (NFO), myelinating oligodendrocyte (MO). Error bars +/− SEM C. 
Log2RPKM values for MAA compared to PBS microglial RNAseq samples (n=4/group). C. 
Principle component analysis of the %mCG/CG from the top 500 most variably methylated 
20 kb windows across the genome of multiple brain cell types including several specific 
types of neurons (excitatory, PV interneurons and VIP interneurons (Mo et al., 2015)), 
astrocytes and total fetal cortex (P28) (Lister et al., 2013). CpG Islands were masked from 
the analysis.
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Figure 3. Differential Methylation between MAA and PBS Microglia
A. Differentially methylated regions (DMRs) with an area statistic >= +/−20 and a 10% or 
greater difference in average methylation between treatments. 1184 DMRs were identified in 
two clusters: hyper-methylation (MAA>PBS, 626 and hypomethylation (PBS>MAA, 558). 
Values shown in the heatmap are the difference from the mean for mCG methylation: % 
mCG/CG minus the mean of %mCG/CG for all samples. See Table S3. B. Distribution of 
DMRs relative to Transcription Start Sites within +/− 5kb of the DMR (HOMER (Heinz et 
al., 2010) annotation). C. Top 20 significantly enriched pathways from MSigDB using 
GREAT annotation of 1184 DMRs. Region Fold Enrichment: observed number of DMRs 
with the annotation/expected number of DMRs with the annotation (McLean et al., 2010). 
See Table S4 for full lists. D. Fisher’s Exact Test Odds Ratios for gene list overlap between 
genes with transcription start sites +/− 5kb from the MAA DMRs. DMR associated genes 
significantly overlapped genes from the microglial (MG) sensome (Hickman et al., 2013), 
primed microglia, genes up-regulated acutely in response to LPS (Holtman et al., 2015), and 
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genes up-regulated in microglia two hours after LPS in males and females at postnatal day 
60 (P60) (Hanamsagar et al., 2017). See Table S7 for full lists and statistics.
Ciernia et al. Page 30
Glia. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. RNA Sequencing Analysis of P35 Microglia
A. Significantly differentially expressed genes (162; FDR q <0.05) are highlighted in red. 
Genes with log fold change >= 2.5 are labeled. B. Heatmap of log2 RPKM values for the 
162 differentially expressed genes between MAA and PBS conditions. Hierarchical clusters 
(k=3) were used to identify patterns of gene expression using hclust in R. See Table S5 for 
gene lists, RPKM values, and statistics. C. MAA differentially expressed and DMR 
associated (+/− 5kb from a DMR) share seven genes. See Table S7 for statistics.
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Figure 5. 
MAA Differentially Expressed and DMR Associated Genes Overlap Genes Dysregulated in 
ASD. A. Gene list overlaps between MAA differentially expressed genes (MAA DE genes), 
MAA DMR associated genes (MAA DMR genes) and ASD genetic risk genes (Sanders et 
al., 2012, 2015; Gilissen et al., 2014; Iossifov et al., 2014a). C. Gene list overlaps between 
MAA DE genes, MAA DMR associated genes and genes differentially expressed, 
methylated, or acetylated in human ASD brain samples (Voineagu et al., 2011; Gupta et al., 
2014; Dunaway et al., 2016b; Parikshak et al., 2016; Sun et al., 2016). D. Gene list overlaps 
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between MAA DE genes, MAA DMR associated genes and MeCP2, FMRP, or CHD8 target 
genes (Darnell et al., 2011; Sugathan et al., 2014; Cotney et al., 2015; Rube et al., 2016). E. 
Gene list overlaps between MAA DE genes, MAA DMR associated genes and genes 
differentially expressed in microglia from Rett syndrome mouse models (Cronk et al., 2015; 
Zhao et al., 2017). Lists are from MeCP2−/y null males (fully symptomatic), MeCP2−/+ 
heterozygous females at either 5 weeks (prior to symptom onset) or at 24 weeks (fully 
symptomatic). * Fisher’s exact test with FDR corrected p-value <0.05. Gene lists, citations 
and individual statistics are listed in Table S7.
Ciernia et al. Page 33
Glia. Author manuscript; available in PMC 2019 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
